logo-loader
Heritage Cannabis

Heritage Cannabis completes acquisition of 30% of Endocanna Health

Heritage has issued Endocanna's principles with 2.7 million shares at C$0.49 per share in exchange for a 10% stake and has also spent C$2 million for an additional 20% holding

Yellow sign reading 'acquisition' in black letters
It plans to introduce to Canada the Endocanna DNA kit, which tests users DNA to determine how it affects their experiences with cannabis

Heritage Cannabis Holdings Corp (CSE:CANN) announced Monday that it has completed its partial acquisition of the cannabis DNA-testing company Endocanna Health Inc.

Heritage has issued Los Angeles-based Endocanna's principles with 2.7 million shares at C$0.49 per share in exchange for a 10% stake and has also spent C$2 million for an additional 20% holding.

The firm plans to introduce to Canada the Endocanna DNA kit, which tests users DNA to determine how it affects their experiences with cannabis.

READ: Heritage Cannabis to supply Cronos with vaporizer devices for Canadian adult-use, medical markets

“We look forward to introducing the Endocanna DNA kit to Canada, and working with the entire team at Endocanna to bring some of our medical formulations to the marketplace,” Heritage CEO Clint Sharples said. “The information that the DNA kit provides, gives people the opportunity to more effectively use cannabis for their medicinal requirements.”

As part of the deal, Endocanna has appointed Heritage Chief Financial Officer Erin Prohaska to its board of directors and Chief Science Officer Chris Spooner to its advisory board.

Heritage saw its shares slip nearly 3% on Monday to C$0.50 on the CSE.

Contact Andrew Kessel at [email protected]

Follow him on Twitter @andrew_kessel

Quick facts: Heritage Cannabis

Price: $0.33

Market: CSE
Market Cap: $144.13 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Heritage Cannabis named herein, including the promotion by the Company of Heritage Cannabis in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks nudge lower but Empower Clinics soars on new...

Cannabis stocks eased slightly on Tuesday as shares remained quiet across US and Canadian markets. The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, lost 1% to hit 178.1 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF eased 0.3%...

5 days, 19 hours ago

2 min read